Screener
GoodRx Holdings, Inc. GDRX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from GoodRx Holdings, Inc.’s reported figures.
The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001809519-26-000152
FAQ
- What is GoodRx Holdings, Inc.'s EBITDA?
- GoodRx Holdings, Inc. (GDRX) reported EBITDA of $45.9M in Q2 2026.
- How has GoodRx Holdings, Inc.'s EBITDA changed year-over-year?
- GoodRx Holdings, Inc.'s EBITDA decreased by 1.4% year-over-year, from $46.54M to $45.9M.
- What is the long-term trend for GoodRx Holdings, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s EBITDA has grown at a 37.8% compound annual growth rate (CAGR), from $47.95M to $172.71M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about GoodRx Holdings, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude